Treat the ADHD Underneath the Cocaine

He was 43. Diagnosed with ADHD as a kid. Two years into a cocaine problem that started at a social event, the way a lot of them do. He had done rehab more than once. He had done the support groups. And he could not stay in remission longer than two weeks — the same ceiling, again and again, the kind of pattern that makes a person quietly decide the problem is them.

His clinicians in Alabama did something a lot of programs still treat as unthinkable. They restarted his ADHD medication. Amphetamine salts, 10 mg twice a day, titrated up over four months. At follow-up he had six and a half months of negative urine screens, and his score on the Cocaine Craving Scale had dropped from 45 to roughly 5.

A craving that never lets you past week two is a clinical signal, not a character flaw.

That case was published in Frontiers in Psychiatry in January. One person. One person is not a protocol, and the authors say so themselves. But it lands on something the field has known and mostly stepped around: roughly 20% of people with cocaine or methamphetamine use disorder have ADHD, against about 6.8% of adults generally. That same Yale-led review lists what the overlap costs — worse retention, lower abstinence rates, more time in hospitals — and then admits there is a real scarcity of double-blind trials run specifically in people who have both.

So if you have sat across from an intake worker who said the clinic would not evaluate you for ADHD until you had a year clean, understand what you were handed. That was a policy. It was not a finding.

None of this makes prescription stimulants a fix. In June’s JAMA Psychiatry meta-analysis of 12 randomized trials, pooling 2,000 people in cocaine and meth pharmacotherapy studies, no medication beat placebo overall. What that analysis actually changed is the scoreboard. By the end of those trials, 13.3% of participants had reached abstinence — but 31.2% had meaningfully reduced their use, more than twice as many. In the cocaine trials abstinence ran at 7.1%. Score it abstinence-or-nothing and you erase most of the people who got better.

Both papers are pointing at the same blind spot from opposite ends. One says the thing driving the craving may be a condition you were diagnosed with in third grade and stopped being treated for. The other says the measuring stick has been throwing away evidence of improvement for years.

What neither says, and what someone should: the two-week ceiling is data. It shows up in the chart the same way a fever does. A man hit it repeatedly through multiple rounds of treatment before anyone read it as information instead of as him. If that pattern is yours, it deserves a workup, not a verdict.